Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Bean

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|December 25, 2014
Altered Transcriptional Control Networks with Trans-Differentiation of Isogenic Mutant-KRas NSCLC ModelsJohn A Haley, Elizabeth Haughney, Erica Ullman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinomaJames Bean, Gregory J Riely, Marissa Balak, et al.
Molecular Pharmacology|June 4, 2005
Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expressionJai Pal Singh, Raymond Kauffman, William Bensch, et al.
Cancer Immunology Research|August 30, 2022
BCG-Induced Tumor Immunity Requires Tumor-Intrinsic CIITA Independent of MHC-IIGil Redelman-Sidi, Anna Binyamin, Anthony C Antonelli, et al.
Clinical & Experimental Metastasis|January 4, 2011
A systems view of epithelial-mesenchymal transition signaling statesStuart Thomson, Filippo Petti, Izabela Sujka-Kwok, et al.
Angewandte Chemie (International Ed. in English)|July 12, 2024
Indazole to 2-Cyanoindole Scaffold Progression for Mycobacterial Lipoamide Dehydrogenase Inhibitors Achieves Extended Target Residence Time and Improved Antibacterial ActivityShan Sun, John Ginn, Tomasz Kochanczyk, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Loss of circulating CD8α<sup>+</sup> NK cells during human <i>Mycobacterium tuberculosis</i> infectionNezar Mehanna, Atul Pradhan, Rimanpreet Kaur, et al.
Scientific Reports|April 29, 2025
CD8α marks a Mycobacterium tuberculosis-reactive human NK cell population with high activation potentialNezar Mehanna, Atul Pradhan, Rimanpreet Kaur, et al.
JCI Insight|October 5, 2018
Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infectionCharles Kyriakos Vorkas, Matthew F Wipperman, Kelin Li, et al.
Neurosurgery|April 5, 2017
A Review and Survey of Neurosurgeon-Hospital Relationships: Evolution and OptionsDong H Kim, Bernard Duco, Daniel Wolterman, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|December 25, 2014
Altered Transcriptional Control Networks with Trans-Differentiation of Isogenic Mutant-KRas NSCLC ModelsJohn A Haley, Elizabeth Haughney, Erica Ullman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinomaJames Bean, Gregory J Riely, Marissa Balak, et al.
Molecular Pharmacology|June 4, 2005
Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expressionJai Pal Singh, Raymond Kauffman, William Bensch, et al.
Cancer Immunology Research|August 30, 2022
BCG-Induced Tumor Immunity Requires Tumor-Intrinsic CIITA Independent of MHC-IIGil Redelman-Sidi, Anna Binyamin, Anthony C Antonelli, et al.
Clinical & Experimental Metastasis|January 4, 2011
A systems view of epithelial-mesenchymal transition signaling statesStuart Thomson, Filippo Petti, Izabela Sujka-Kwok, et al.
Angewandte Chemie (International Ed. in English)|July 12, 2024
Indazole to 2-Cyanoindole Scaffold Progression for Mycobacterial Lipoamide Dehydrogenase Inhibitors Achieves Extended Target Residence Time and Improved Antibacterial ActivityShan Sun, John Ginn, Tomasz Kochanczyk, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Loss of circulating CD8α<sup>+</sup> NK cells during human <i>Mycobacterium tuberculosis</i> infectionNezar Mehanna, Atul Pradhan, Rimanpreet Kaur, et al.
Scientific Reports|April 29, 2025
CD8α marks a Mycobacterium tuberculosis-reactive human NK cell population with high activation potentialNezar Mehanna, Atul Pradhan, Rimanpreet Kaur, et al.
JCI Insight|October 5, 2018
Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infectionCharles Kyriakos Vorkas, Matthew F Wipperman, Kelin Li, et al.
Neurosurgery|April 5, 2017
A Review and Survey of Neurosurgeon-Hospital Relationships: Evolution and OptionsDong H Kim, Bernard Duco, Daniel Wolterman, et al.
Pageof 2